BOSTON--(BUSINESS WIRE)--ArkeaBio™, a leading ag-biotech start-up developing a vaccine to reduce livestock methane emissions, today announced the close of a $26.5 million Series A financing round. The raise was led by current investor Breakthrough Energy Ventures (BEV), and attracted additional investors, including The Grantham Foundation for the Protection of the Environment, AgriZeroNZ, Rabo Ventures, Overview Capital, and The51 Food & AgTech Fund..

波士顿--（商业新闻短讯）--ArkeaBio™是一家领先的ag生物技术初创公司，正在开发一种减少牲畜甲烷排放的疫苗，今天宣布结束一轮2650万美元的a系列融资。此次融资由目前的投资者突破性能源投资公司（BEV）牵头，并吸引了更多投资者，包括格兰瑟姆环境保护基金会、AgriZeroNZ、Rabo Ventures、Overview Capital和51 Food&AgTech Fund。。

ArkeaBio’s vaccine will provide an innovative, cost-effective, and scalable solution to reduce the world’s livestock methane emissions, which currently generate the equivalent of 3 Billion Tonnes of CO2 annually and represent 6% of annual Greenhouse gas emissions. “Reducing methane emissions from the agricultural sector is one of the most pressing challenges in today’s fight against climate change,” said Chris Rivest, Chairman of the Board at ArkeaBio and partner at Breakthrough Energy Ventures.

ArkeaBio的疫苗将为减少全球牲畜甲烷排放提供一种创新、经济且可扩展的解决方案，目前每年产生相当于30亿吨二氧化碳的二氧化碳，占每年温室气体排放量的6%。“减少农业部门的甲烷排放是当今应对气候变化斗争中最紧迫的挑战之一，”ArkeaBio董事会主席兼突破性能源投资公司合伙人克里斯·里维斯特（ChrisRivest）表示。

“ArkeaBio’s approach using innovative vaccine technologies will create effective and massively scalable solutions to reduce on-farm methane emissions, leaving them well-positioned to redefine the agricultural landscape in the years to come.”.

“ArkeaBio使用创新疫苗技术的方法将创造有效且大规模可扩展的解决方案，以减少农场甲烷排放，使其在未来几年重新定义农业景观。”。

ArkeaBio research and development results have garnered substantial attention from investors for the advancement of the inaugural methane-reducing vaccine, designed for safe and rapid implementation within existing on-farm practices. The funds raised in this Series A financing will play a pivotal role in expanding the research, development and deployment of the vaccine, including large-scale field trials and engagement along the supply chain.

ArkeaBio的研究和开发结果引起了投资者的极大关注，因为该公司推出了首个甲烷减少疫苗，旨在在现有的农场实践中安全快速地实施。在这一系列A融资中筹集的资金将在扩大疫苗的研究，开发和部署方面发挥关键作用，包括大规模的现场试验和供应链的参与。

“We are thankful for the financial support, confidence, and trust of our investors. This funding will accelerate the development of our vaccine-based solution to meet a pressing global problem,” said Colin South, ArkeaBio CEO. “To echo the sentiments of The Grantham Foundation: ‘climate change is the greatest challenge humanity has ever faced.

ArkeaBio首席执行官科林·南特（ColinSouth）表示：“我们感谢投资者的财政支持、信心和信任。这笔资金将加速我们基于疫苗的解决方案的开发，以应对紧迫的全球问题。”。回应格兰瑟姆基金会的观点：“气候变化是人类有史以来面临的最大挑战。

It is the race of our lives.’ This capital raise allows us to continue to create the tools necessary for farmers to achieve globally relevant reductions in livestock methane emissions.”.

这是我们生命的竞赛。”此次融资使我们能够继续为农民创造必要的工具，以实现与全球相关的牲畜甲烷减排。”。

ArkeaBio is dedicated to collaborative efforts with industry partners, regulatory authorities, and environmental organizations to bring this transformative solution to market.

ArkeaBio致力于与行业合作伙伴、监管机构和环境组织合作，将这一变革性解决方案推向市场。

Additional Investor Statements:

其他投资者声明：

'Enteric methane emissions are responsible for around 10% of global warming. Enteric methane emissions are also very hard to abate. New technologies can help to prevent accelerating methane emissions from the agricultural sector. We are excited to support ArkeaBio's development of methane vaccines for ruminants on their pathway to commercialization.'.

“肠道甲烷排放约占全球变暖的10%。肠道甲烷排放也很难减少。新技术可以帮助防止农业部门加速甲烷排放。我们很高兴支持ArkeaBio在反刍动物商业化道路上开发甲烷疫苗。”。

- The Grantham Foundation for the Protection of the Environment

-格兰瑟姆环境保护基金会

“A methane vaccine for ruminant animals is internationally recognised as the ‘holy grail’ to deliver methane reduction at low cost and mass scale. It could be one of the best long-term options to really shift the dial on agricultural emissions and a powerful tool globally. We’re really pleased to be supporting ArkeaBio and its innovative approach to develop this important solution.”.

“反刍动物甲烷疫苗被国际公认为以低成本和大规模减少甲烷的‘圣杯’。它可能是真正改变农业排放的最佳长期选择之一，也是全球强大的工具。我们非常高兴支持ArkeaBio及其创新方法来开发这一重要解决方案。”。

- AgriZeroNZ

-AgriZeroNZ

‘'As a cooperative bank, we want to future-proof our global food system by supporting and offering solutions that have the potential to reduce the environmental impact of agriculture. In our search for solutions that can lower the footprint of livestock farming and be applicable across all feeding systems, ArkeaBio emerged as a game-changing solution.

“作为一家合作银行，我们希望通过支持和提供有可能减少农业对环境影响的解决方案来证明我们的全球粮食系统的未来。在我们寻找能够降低畜牧业足迹并适用于所有饲养系统的解决方案时，ArkeaBio成为了一个改变游戏规则的解决方案。

Their cost-effective, easy-to-deploy and high-quality vaccines have the potential to be a critical tool as part of the broader set of solutions that enable the food systems transition.''.

它们具有成本效益，易于部署和高质量的疫苗有可能成为一种关键工具，作为实现粮食系统转型的更广泛解决方案的一部分。

- Rabo Ventures

-Ass Ventures

ABOUT ARKEABIO™

关于活动™

ArkeaBio™ is an ag-biotech start-up developing a safe, user-friendly, and cost-conscious vaccine to reduce ruminant methane emissions that will work seamlessly with existing global agribusiness practices. With a record of success and a growing reputation in the industry, ArkeaBio has emerged as a leading player known for its cutting-edge solutions, ground-breaking research, and unwavering commitment to changing the sustainable agricultural landscape as we know it.

ArkeaBio™是一家ag生物技术初创公司，正在开发一种安全，用户友好且具有成本意识的疫苗，以减少反刍动物甲烷的排放，该疫苗将与现有的全球农业综合企业实践无缝结合。ArkeaBio取得了巨大的成功，并在业界享有越来越高的声誉，它以其尖端的解决方案、开创性的研究以及对改变我们所知的可持续农业格局的坚定承诺而闻名于世。

For more information, please visit www.arkeabio.com..

欲了解更多信息，请访问www.arkeabio.com。。

ABOUT BREAKTHROUGH ENERGY VENTURES (BEV)

关于突破性能源投资（BEV）

A founding investor at ArkeaBio, BEV is backed by many of the world’s top business leaders, BEV has raised more than $2 billion in committed capital to support cutting-edge companies that are leading the world to net-zero emissions. BEV is a purpose-built investment firm that is seeking to invest, launch and scale global companies that will eliminate GHG emissions throughout the economy as soon as possible.

作为ArkeaBio的创始投资者，BEV得到了许多世界顶级商业领袖的支持，BEV已经筹集了20多亿美元的承诺资本，以支持引领世界实现净零排放的尖端公司。BEV是一家专门设立的投资公司，正在寻求投资、成立和扩大全球公司规模，以尽快消除整个经济体的温室气体排放。

BEV seeks true breakthroughs and is committed to supporting these entrepreneurs and companies by bringing to bear a unique combination of technical, operational, market and policy expertise..

BEV寻求真正的突破，并致力于通过将技术、运营、市场和政策专业知识的独特组合来支持这些企业家和公司。。

BEV is a part of Breakthrough Energy, a network of investment vehicles, philanthropic programs, policy advocacy and other activities committed to scaling the technologies we need to reach net-zero emissions by 2050. Visit www.breakthroughenergy.org to learn more.

BEV是突破能源的一部分，突破能源是一个由投资工具、慈善计划、政策倡导和其他活动组成的网络，致力于扩大我们到2050年实现净零排放所需的技术。访问www.breakthroughenergy.org了解更多信息。

ABOUT THE GRANTHAM FOUNDATION FOR THE PROTECTION OF THE ENVIRONMENT

关于格兰瑟姆环境保护基金会

The Grantham Foundation for the Protection of the Environment, and its affiliate, Grantham Environmental Trust, believe that innovation and technology are the best hope for an enduring future. The Grantham Trust and Foundation have, for over 15 years, focused almost exclusively on climate change mitigation and support over 150 grantees and 90 companies around the world.

格兰瑟姆环境保护基金会（GranthamFoundation for The Protection of The Environment）及其附属机构格兰瑟姆环境信托（GranthamEnvironmental Trust）认为，创新和技术是实现持久未来的最大希望。格兰瑟姆信托基金会（GranthamTrust and Foundation）在过去15年中，几乎完全专注于缓解气候变化，并支持全球150多家受赠人和90多家公司。

For more information, visit https://www.granthamfoundation.org/..

For more information, visit https://www.granthamfoundation.org/..

ABOUT AGRIZERONZ

关于AGRIZERONZ

AgriZeroNZ is a world-first public-private partnership between the New Zealand Government and agribusiness companies with an ambition to reduce agricultural emissions by 30% by 2030 and enable the development and adoption of solutions to drive towards ‘near zero’ by 2040. It is one of two key components of the Centre for Climate Action on Agricultural Emissions, working alongside the New Zealand Agricultural Greenhouse Gas Reduction Centre.

AgriZeroNZ是新西兰政府和农业企业之间的全球首家公私合作伙伴关系，其目标是到2030年将农业排放量减少30%，并使解决方案的开发和采用能够在2040年实现“接近零”的目标。它是农业排放气候行动中心的两个关键组成部分之一，与新西兰农业温室气体减排中心合作。

Shareholders have joined forces and pooled funds to drive a focus on delivering game-changing solutions to rapidly reduce emissions and will help New Zealand farmers meet global customer demands while maintaining profitability. Please see https://www.agrizero.nz/ for further information..

股东们联手并筹集资金，致力于提供改变游戏规则的解决方案，以快速减少排放，并将帮助新西兰农民满足全球客户需求，同时保持盈利能力。请参见https://www.agrizero.nz/更多信息。。

ABOUT RABO VENTURES

关于RABO VENTURES

Rabo Ventures aims to support the vital transitions needed in the global food system, which are closely linked to Rabobank’s sustainability ambitions. We invest across the value chain – from farm to fork – in stellar management teams building solutions for real problems in Food & Agriculture with demonstrable product-market fit.

Rabo Ventures旨在支持全球粮食系统所需的重要转型，这与Rabobank的可持续发展目标密切相关。我们在整个价值链（从农场到叉子）上投资于一流的管理团队，为食品和农业的实际问题构建解决方案，并具有明显的产品市场适应性。

For more information, please visit https://raboinvestments.com/team/ventures/..

有关更多信息，请访问https://raboinvestments.com/team/ventures/..

ABOUT OVERVIEW CAPITAL

关于概述资本

Overview Capital invests in businesses mitigating methane and other super pollutants in the earliest stages. To learn additional insights, please see https://www.overview.earth/.

概述资本投资于最早阶段缓解甲烷和其他超级污染物的企业。要了解更多见解，请参阅https://www.overview.earth/.

ABOUT THE51 FOOD & AGTECH FUND

关于51食品与农业技术基金

The51 Food & AgTech Fund invests in founders solving the planet's greatest challenges through food and agriculture innovation. The Fund represents a joint venture between The51 Ventures and CNSRV-X. To learn more, please visit www.51agtech.com.

51食品与农业技术基金投资于通过食品和农业创新解决地球最大挑战的创始人。该基金代表51家合资企业和CNSRV-X之间的合资企业。要了解更多信息，请访问www.51agtech.com。